Each September, Childhood Cancer Awareness Month brings attention to the fight against pediatric cancers. One of the promising projects currently making waves in this field is MONALISA, a Horizon Europe-funded initiative under the EU Cancer Mission.
The NHS is looking for volunteers as part of the three cancer projects that have been selected as part of the NHS DigiTrials initiative. Almost 150,000 volunteers will take part in these trials to help transform cancer treatment.
Gareth Jenkins, a partner at Changeology Group Ltd, discusses the potential of detailed analysis to enhance the efficiency of cancer care within the NHS.
Driven by personal loss, this healthcare leader shares how their organisation (SAH Diagnostics) partners with the NHS, combining innovation and clinical excellence to reduce NHS cancer backlogs and improve patient outcomes in an exclusive interview with Open Access Government.
Researchers at University College London (UCL) have developed a miniature scanner that could transform the way doctors diagnose and manage diseases such as cancer, diabetes, and arthritis.
Researchers at Case Western Reserve University and the Louis Stokes Cleveland VA Medical Center have secured a four-year, $1.14 million grant from the U.S. Department of Veterans Affairs.
Asal Shirazi, Founder and CEO of the Autoimmune Support and Awareness (ASA) Foundation, discusses the increased prevalence of cancer in the UK and the challenges facing NHS England as it works to tackle backlogs in cancer care.
As the UK’s healthcare system continues to struggle with care and cancer backlogs, Gareth Jenkins of Changeology Group Ltd explains how the company can assist healthcare teams in making positive operational changes that enhance efficiency and patient outcomes.
Milena Angelova, EESC member and Rapporteur for the EESC opinion on Vaccine-preventable cancers, highlights the vital role of civil society in eradicating them.
Researchers have unveiled a pioneering method that could revolutionise the early detection of pancreatic cancer, a disease known for its late diagnosis and low survival rates.
A new study led by researchers at University College London (UCL) suggests that routine blood tests could significantly enhance early cancer diagnosis for individuals experiencing stomach pain or bloating.
New research highlights a crucial consideration for men battling prostate cancer, a potentially heightened risk of heart disease when certain medications are combined.
Hailey Coverson, Data Scientist at Bayezian, discusses the complexities of genomic data, accounting for biases and inaccuracies and AI’s potential in supporting clinical decisions in breast cancer care.
